Clinical Trials Logo
  1. Home
  2. Bioequivalence Study
  3. NCT04229602

Bioequivalence Study of Venlafaxine Hydrochloride Sustained-Release Capsules in Chinese Healthy Volunteers

Bioequivalence Study Clinical Trial

Official title:
Bioequivalence Study of Venlafaxine Hydrochloride Sustained-Release Capsules and EFEXOR® XR Under Fed Conditions in Chinese Healthy Volunteers

Clinical Trial Summary

The objective of this study is to evaluate the human bioequivalence of two Venlafaxine Hydrochloride Sustained-Release Capsules (75 mg) .

Clinical Trial Description

The objective of this study is to evaluate the human bioequivalence of Venlafaxine Hydrochloride Sustained-Release Capsules (75 mg) produced by Beijing Winsunny Pharmaceutical Co., Ltd and EFEXOR® XR (75mg) produced by Pfizer Ireland Pharmaceuticals(held by Pfizer Healthcare Ireland, distributed by Wyeth pharmaceutical co. LTD), as well as the safety of the tested preparation, and to provide basis for the evaluation of the quality and efficacy consistency of the tested preparation and the reference preparation. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04229602
Study type Interventional
Source Beijing Tongren Hospital
Contact Feng Wu, Dr
Phone 0086-10-58268486
Email trdrug@126.com
Status Recruiting
Phase N/A
Start date January 2, 2020
Completion date July 2, 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT03050164 - Bioequivalence Study of Gefitinib Tablets Under Fasting Conditions Phase 1
Not yet recruiting NCT06441916 - Bioequivalence Study of Dabigatran Etexilate Capsules 150 mg in Healthy Thai Volunteers Under Fasting Conditions Phase 1
Completed NCT04877834 - Bioequivalence Study of DelanzoᵀᴹDR 60mg (Dexlansoprazole) Capsule With Dexilant® 60mg (Dexlansoprazole) Capsule in Healthy Pakistani Subjects. Phase 1
Not yet recruiting NCT06058689 - A Pilot Bioequivalence Study of Pomalidomide Phase 1
Completed NCT05436769 - Bioequivalence Study of Klaribact (Clarithromycin) 500 mg, Film Coated Tablet Phase 1
Completed NCT04585321 - Comparative Bioavailability and Local Tolerability of Two Topical Diclofenac Plasters Applied Once and Twice a Day Phase 1
Completed NCT04873570 - Bioequivalence Study of Mofest® 400mg (Moxifloxacin) Tablet With Avelox® 400mg (Moxifloxacin) Tablet in Healthy Pakistani Subjects Phase 1
Completed NCT01595425 - Bioequivalence Study Comparing D961H Sachet and D961H Capsule in Japanese Healthy Male Subjects Phase 1
Recruiting NCT05794919 - Bioequivalence Study of Calcium Hydroxybenzene Sulphonate Dispersible Tablets in Chinese Healthy Volunteers N/A
Completed NCT04358770 - Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream Phase 1
Completed NCT03602300 - A Phase 1 Bioequivalence Study of a Test Tablet Formulation of Ravidasvir With the Reference Tablet Formulation of Ravidasvir Study Phase 1
Completed NCT05436886 - Bioequivalence Study of Neurogabin-M (Gabapentin 400 mg) Capsule With Parketin (Gabapentin 400 mg) Capsules N/A
Completed NCT01494402 - Study to Assess the Bioequivalence Between D961S and Esomeprazole/Buffered Acetylsalicylic Acid (ASA) in Japanese Healthy Male Subjects Phase 1
Completed NCT03765944 - Bioequivalence Study of NPC-12 (Sirolimus) Granules and Tablets Phase 1
Not yet recruiting NCT06273254 - A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions Phase 1